logo-top-r-w
  • HOME
  • ABOUT MORSE
    • The Team
    • Careers
  • SERVICES
    • Our Services
      • Comprehensive Market Access Launch Strategy
      • Market Access Landscape Analysis
      • HTA Planning and Reimbursement Evidence Strategy
      • Negotiation & Stakeholder Engagement Strategy
      • Portfolio & Life Cycle Strategy
      • Expert-Led Training & Customized Workshops
  • REPORTS
    • NEW – Order CRaFT 2026
    • DRD Market Access Trends & Insights
    • Oncology Market Access Trends & Insights
    • Managing Loss of Exclusivity Report
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
    • Cracking the Code 2.0
  • LINKS
  • CONTACT US
logo-top-r
logo-top-r-w
  • HOME
  • ABOUT MORSE
    • The Team
    • Careers
  • SERVICES
    • Our Services
      • Comprehensive Market Access Launch Strategy
      • Market Access Landscape Analysis
      • HTA Planning and Reimbursement Evidence Strategy
      • Negotiation & Stakeholder Engagement Strategy
      • Portfolio & Life Cycle Strategy
      • Expert-Led Training & Customized Workshops
  • REPORTS
    • NEW – Order CRaFT 2026
    • DRD Market Access Trends & Insights
    • Oncology Market Access Trends & Insights
    • Managing Loss of Exclusivity Report
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
    • Cracking the Code 2.0
  • LINKS
  • CONTACT US

MORSE Consulting Releases its 2018 pCPA Year in Review Infographic

March 7, 2019
-
Market Access News, Publications
-
Posted by MORSE Team - < 1 min read.

MORSE Consulting is pleased to release its 2018 pCPA Year in Review infographic.  The purpose of this resource is to help market access professionals provide a top-line pCPA performance summary to both internal and external stakeholders.

This infographic compares the negotiation activities of the pCPA in 2018 to 2017 as it relates to:

  • completed negotiations by source (CDR, pCODR, pCPA initiated);
  • a breakdown of pCPA initiated files; and
  • completed negotiation timelines.

Click for full-size

 

A complimentary PDF version of the infographic can be printed or downloaded HERE.

Embed this infographic (cut and paste code) on your website with attribution:

 

To receive updates similar to this one please be sure to sign up for MORSE Signals, our free e-mail newsletter service.

Share
Tags
CDR
Pan Canadian Pharmaceutical Alliance
pCODR
pCPA
pCPAO
← PREVIOUS POST
pCPA Trends and Insights - Two Biosimilars Initiated Negotiations and Two Multi-Indication Negotiations were Completed
NEXT POST →
Summary of PMPRB Webinar on Meds Entry Watch, 2017

Contact Us

MORSE Consulting Inc.

Toronto | Ottawa, Canada

+1-647-717-3179 (Toronto)

+1-613-864-8645 (Ottawa)

info@morseconsulting.ca

CTC Event Vancouver

Carcking the code Vancouver

Pre-order 2026 Report

2025 Canadian Reimbursement and Forecasting Timelines Report

Newsletter – MORSE Signals
Sign up for our free e-mail newsletter service and receive timely and relevant updates related to the emerging developments in the Canadian pharmaceutical reimbursement landscape.

Sign Up
Social
Connect & Follow:
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2026 MORSE Consulting Inc. All rights reserved. | Site by Directica Media
MORSE Consulting Releases its 2018 pCPA Year in Review Infographic
Learn More
Learn More

You're viewing an older edition

The latest CRaFT 2026 report has updated reimbursement data, forecasts, and trends. Get the most current insights.

View the 2026 CRaFT Report → Go to homepage